TAZ interacts with DNA binding proteins of the TEA/ATTS domain (TEAD) family to activate transcription of target genes, such as CTGF (encoding connective tissue growth factor), which promote epithelial-mesenchymal transition and the breast cancer stem-cell phenotype [14-18]. Here, CCN2 is linked to breast cancer.